Gerresheimer (GXI) Q4 2025 earnings summary

Executive summary

• Extensive compliance and forensic investigations concluded, resulting in a restatement of 2024 financials and a clean, audited 2025 annual report.

• Management focus on governance, transformation, and disciplined execution, with new executive board and broad creditor support via stabilization agreement.

• Strategic priorities include the sale of Centor and comprehensive debt refinancing, both targeted for completion in 2026.

• Gerresheimer Transformation Offensive (GTO/gto) launched, targeting operational and cash excellence, fast payback, and improved profitability.

Financial highlights

• 2024 restated revenue down 2% (€45m) and EBITDA down 7% (€31m) due to corrections from investigations; 2025 impairments totaled €258m.

• 2025 revenue at €2.3bn, up 17% year-over-year, mainly from Bormioli acquisition; organic/legacy growth flat.

• Adjusted EBITDA margin for 2025 at 16.8%, within guidance; adjusted EBITDA down 1% year-over-year to €384m.

• EPS at -€1.65, reflecting significant one-time items and restructuring challenges.

• Free cash flow before M&A at -€86m, with CapEx of €295m (one-third base, two-thirds growth).

Outlook and guidance

• 2026 revenue expected in the lower half of €2.3bn–€2.4bn range due to economic headwinds, project delays, and operational challenges.

• Adjusted EBITDA margin guided at 17%–18%; free cash flow before M&A between -€50m and -€100m.

• GTO/gto expected to contribute €10m–€20m EBITDA in 2026, with midterm targets of 200–400bps profitability improvement.

• Acceleration of revenue growth and margin improvement anticipated in the second half of the year.